A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
11/2001
11/29/2001	CA2408783A1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/29/2001	CA2408727A1 Benzophenones as inhibitors of il-1.beta. and tnf-.alpha.
11/29/2001	CA2408709A1 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	CA2408562A1 Dehydroascorbic acid formulations and uses thereof
11/29/2001	CA2408315A1 Aminoacyl trna synthetases
11/29/2001	CA2408140A1 G-protein coupled receptors
11/29/2001	CA2407780A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	CA2407545A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof
11/29/2001	CA2407028A1 Pharmaceutical combination of bicalutamide and tamoxifen for providing an anti-androgenic effect and an anti-oestrogenic effect
11/29/2001	CA2406829A1 Protease inhibitors
11/29/2001	CA2380935A1 Caspase inhibitors and uses thereof
11/28/2001	EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2)
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158002A1 Human G-protein coupled receptor
11/28/2001	EP1157998A1 Heterocyclic compounds, intermediates thereof and elastase inhibitors
11/28/2001	EP1157698A2 Treatment of inflammatory diseases with oxypurine nucleosides
11/28/2001	EP1157275A1 Novel transduction molecules and methods for using same
11/28/2001	EP1157126A1 Method for cloning signal transduction intermediates
11/28/2001	EP1157104A2 Pyk2 binding proteins
11/28/2001	EP1157101A1 Drug design based on the structure of lta 4? hydrolase
11/28/2001	EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
11/28/2001	EP1157040A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction
11/28/2001	EP1157026A1 Polycyclo heterocyclic derivatives as antiinflammatory agents
11/28/2001	EP1157025A1 Pyrazolopyridines
11/28/2001	EP1157024A1 Acetylenic ortho-sulfonamido and phosphinic acid amido bicyclic heteroaryl hydroxamic acids as tace inhibitors
11/28/2001	EP1157022A1 Pyridine compounds and their pharmaceutical use
11/28/2001	EP1157021A1 Sulfamato hydroxamic acid metalloprotease inhibitor
11/28/2001	EP1157006A2 Phenyl- and pyridinyl derivatives as neurokinin 1 antagonists
11/28/2001	EP1157005A1 3-phenylpyridine derivatives and their use as nk-1 receptor antagonists
11/28/2001	EP1157003A1 Acylated aminoacetonitriles as cysteine protease inhibitors
11/28/2001	EP1157000A1 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of diabetic retinopathy
11/28/2001	EP1156999A1 Method for the preparation of a chiral-beta-amino ester
11/28/2001	EP1156855A1 Composition comprising a tramadol material and a selective cox-2 inhibitor drug
11/28/2001	EP1156820A1 Vascular endothelial growth factor-2
11/28/2001	EP1156794A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen
11/28/2001	EP1156771A2 Interferon tau mutants and methods for making them
11/28/2001	EP1054685B1 Liquid crystal forms of cyclosporin
11/28/2001	EP0914129B1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents
11/28/2001	EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors
11/28/2001	EP0804469B1 T-cell affecting peptides
11/28/2001	EP0804225B1 Pharmaceutical compositions comprising a superoxide dismutase
11/28/2001	EP0677051B1 Derivatives of benzoylecgonine, ecgonine and ecgonidine as medicines
11/28/2001	CN1324403A PRV-1 gene and the use thereof
11/28/2001	CN1324360A Bicyclic nitrogen heterocycles
11/28/2001	CN1324354A Vitreous form of know bradykinin antagonist
11/28/2001	CN1324353A Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/28/2001	CN1324352A 2-phenylpyran-4-one derivatives
11/28/2001	CN1324350A Benzoylpyridazines
11/28/2001	CN1324347A Arylpiperzines as metalloproteinase inhibiting agents (MMP) and their use
11/28/2001	CN1324344A N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them
11/28/2001	CN1323622A Rheumatism treating traditional Chinese medicine prepn. and its prepn. process
11/28/2001	CN1323618A Rheumatism treating plaster
11/28/2001	CN1323611A Rheumatism treating medicine
11/28/2001	CN1323604A Foamed disease-treating ointment
11/28/2001	CN1075372C Indomethacin adhesive plaster
11/27/2001	US6323234 Methods to treat gastrointestinal lesions and to reduce drug-induced gastrointestinal or renal toxicity
11/27/2001	US6323223 Ccr-3 receptor antagonists, pharmaceutical compositions containing them, methods for their use and methods for preparing these compounds.
11/27/2001	US6323222 1-aza-2-alkyl-6-aryl-cycloalkane compounds
11/27/2001	US6323214 Allosteric adenosine receptor modulators
11/27/2001	US6323210 Transferase inhibitor
11/27/2001	US6323204 Analgesics, antiinflammatory agents and antiischemic agents
11/27/2001	US6323201 Compounds for inhibition of ceramide-mediated signal transduction
11/27/2001	US6323199 Aromatic heterocyclic hydroxy amines or amides for treatment of inflammation
11/27/2001	US6323184 Arteriovenous and venous graft treatments: methods and compositions
11/27/2001	US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases
11/27/2001	US6322816 Fast-acting analgesic
11/27/2001	US6322806 Over-coated chewing gum formulations including tableted center
11/27/2001	US6322791 Haemopoietic growth factor antagonists and uses therefor
11/27/2001	US6322770 Indazole vitronectin receptor antagonist pharmaceuticals
11/27/2001	CA2021329C Di-aromatic esters, process for their preparation and use in human or veterinary medicine and as cosmetic compositions
11/26/2001	CA2316405A1 Modulation of inflammation by protease products
11/25/2001	CA2309518A1 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
11/22/2001	WO2001088119A1 Novel g protein-coupled receptor protein and dna thereof
11/22/2001	WO2001087979A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087977A2 Methods and compositions of matter concerning april/g70, bcma, blys/agp-3, and taci
11/22/2001	WO2001087938A2 Polynucleotide sequence encoding a putative cell adhesion molecule
11/22/2001	WO2001087923A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
11/22/2001	WO2001087913A2 Method for treating retinal degeneration with purinergic receptor agonists
11/22/2001	WO2001087890A1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
11/22/2001	WO2001087889A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087887A2 Neuroprotective and anti-proliferative compounds
11/22/2001	WO2001087886A1 Crf receptor antagonists and methods relating thereto
11/22/2001	WO2001087883A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087880A1 1-(benzothiazol-2-yl)pyrazole derivatives and cox-2 inhibitors containing the same
11/22/2001	WO2001087877A1 Novel thiophenamide compounds
11/22/2001	WO2001087870A1 Hydroxamic acid derivatives
11/22/2001	WO2001087866A1 Cyclohexyl derivatives and their use as therapeutic agents
11/22/2001	WO2001087849A2 Modulators of tnf- alpha signaling
11/22/2001	WO2001087846A2 Tricyclic pyrazole derivatives as protein kinase inhibitors
11/22/2001	WO2001087844A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity
11/22/2001	WO2001087839A1 Pharmaceutically active piperidine derivatives, in particular as modulators of chemokine receptor activity
11/22/2001	WO2001087838A1 Cyclohexane derivatives and their use as therapeutic agents
11/22/2001	WO2001087828A1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
11/22/2001	WO2001087823A1 Novel aryl, alkenyl, and alkynl 4-dedimethylaminotetracycline derivatives
11/22/2001	WO2001087376A1 Drug/drug delivery systems for the prevention and treatment of vascular disease
11/22/2001	WO2001087374A1 Delivery systems for treatment of vascular disease
11/22/2001	WO2001087373A1 Delivery devices for treatment of vascular disease
11/22/2001	WO2001087348A2 Multifunctional nanodevice platform
11/22/2001	WO2001087343A2 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
11/22/2001	WO2001087342A2 Delivery devices for treatment of vascular disease

1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 1272